Variation of abscess formation in cattle after vaccination with a modified-live Pasteurella haemolytica vaccine.
During the spring of the first year of a vaccine study, 57 of 238 calves (24%), in which modified-live Pasteurella haemolytica vaccine (MLV) was injected twice, developed 1 or more abscesses. Abscesses were not observed after multiple visual examinations of 437 calves given killed P haemolytica bacterin or placebo injections of similar adjuvants used in the vaccine and bacterin. Calves that developed abscesses after the second injection of MLV weighed significantly (P < 0.05) less (on the basis of body weight adjusted for weaning weight) at the second injection than did those that did not develop abscesses. Compared with calves given MLV that did not develop observable abscesses, calves developing abscesses after the second injection of MLV weighed 11.0 and 14.2 kg less, respectively, at 56 days and 112 days after injection, and they had 11.0 kg less gain at 56 days after injection. Abscess prevalence tended to be highest on certain days or at certain locations used for cattle processing, and the prevalence of abscesses increased in cattle processed later on a given day. Abscesses were not observed in 2 other groups of similarly treated calves vaccinated in the autumn or in the subsequent spring.
Littledike
E T
ET
USDA, Agricultural Research Service, Roman L. Hruska US Meat Animal Research Center, Clay Center, NE 68933.
D000038:Abscess / Q000453:epidemiology / Q000382:microbiology / Q000662:veterinary*; D000276:Adjuvants, Immunologic / Q000009:adverse effects; D000818:Animals; D001428:Bacterial Vaccines / Q000009:adverse effects*; D001835:Body Weight; D002417:Cattle; D002418:Cattle Diseases / Q000453:epidemiology / Q000382:microbiology*; D016978:Mannheimia haemolytica / Q000276:immunology*; D015995:Prevalence; D014613:Vaccines, Attenuated / Q000009:adverse effects
D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines; D014613:Vaccines, Attenuated